Aevi Genomic Medicine Inc (NASDAQ:GNMX)

2.24
Delayed Data
As of Feb 16
 +0.01 / +0.45%
Today’s Change
0.98
Today|||52-Week Range
6.18
+86.67%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization177.0K225.0K240.0K268.0K
 
 
 
 
 
 
Operating ExpensesGross Income-177.0K-225.0K-240.0K-268.0K
 
 
 
 
 
General Expenses17.5M18.7M28.2M40.4M
 
 
 
 
 
Research And Development7.3M8.3M15.4M28.4M
 
 
 
 
 
Total Operating Expenses17.6M18.9M28.4M40.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-17.6M-18.9M-28.4M-40.7M
 
 
 
 
 
Extraordinary Credit720.0K585.0K0.000.00
 
 
 
Extraordinary Charge-186.0K---9.5M-1.2M
 
 
 
 
Interest Expense On Debt0.0020.0K20.0K15.0K
 
 
 
 
Other Expenses-17.0K-48.0K-18.0K-4.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-17.1M-18.4M-38.0M-41.9M
 
 
 
 
 
Income Taxes-17.0K-12.0K-17.0K-16.0K
 
 
 
 
 
Net Income-17.1M-18.4M-38.0M-41.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS17.6M19.2M26.8M35.2M
 
 
 
 
 
Shares To Calculate EPS Diluted17.7M19.3M26.8M35.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.06-$1.00-$1.45-$1.19
 
 
 
 
 
EPS Diluted-$1.06-$1.00-$1.45-$1.19